| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | SVP, Chief Medical Officer
2 companies
Meyers Michael L. is a SVP, Chief Medical Officer at Syndax Pharmaceuticals Inc with holdings across 2 companies. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 26, 2021 | SNDX Syndax Pharmaceuticals Inc | SVP, Chief Medical Officer | Buy | 500 | $15.46 | $7,730.00 | +3.3% | -10.7% | +2.0% | |
| Mar 21, 2019 | SNDX Syndax Pharmaceuticals Inc | SVP, Chief Medical Officer | Buy | 1,104 | $4.92 | $5,436.48 | +8.3% | - | - | |
| Oct 30, 2018 | SNDX Syndax Pharmaceuticals Inc | SVP, Chief Medical Officer | Buy | 200 | $4.79 | $958.00 | +9.1% | - | - |